Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.
This prospective German NICO study (NCT02990611) evaluated real‑world outcomes with nivolumab plus ipilimumab versus n...